TY - JOUR T1 - Highlights from this issue JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - i LP - i DO - 10.1136/bjophthalmol-2012-302567 VL - 96 IS - 10 AU - Harminder Singh Dua AU - Arun D Singh Y1 - 2012/10/01 UR - http://bjo.bmj.com/content/96/10/i.abstract N2 - Moshfeghi et al describe results of a Phase 1, non invasive ‘radiation-first’ combination treatment, with a low-voltage x-ray irradiation system (16 Gy) followed by as needed ranibizumab for neovascular AMD. Thirteen patients were enrolled and completed 12 months follow-up. There were no serious ocular/non-ocular adverse events or radiation-related ocular complications. Eleven patients lost <15 and 0 gained ≥15 ETDRS letters. The visual acuity stabilising effect was related to reduction in retinal thickness. (see page 1320) Takamura et al compared the efficacy and safety of 3% diquafosol ophthalmic solution with 0.1% sodium hyaluronate ophthalmic solution in 286 dry eye patients randomised to the treatment groups in a 1 : 1 ratio. After 4 weeks, the intergroup difference in the mean change from baseline in fluorescein staining score was −0.03; this verified the non-inferiority of diquafosol. The mean change from baseline in rose Bengal staining score was significantly lower in … ER -